US Stock MarketDetailed Quotes

MBIO Mustang Bio

Watchlist
  • 0.3209
  • -0.0192-5.65%
Close Jul 19 16:00 ET
  • 0.3250
  • +0.0041+1.28%
Post 19:57 ET
11.21MMarket Cap-72P/E (TTM)

About Mustang Bio Company

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Worcester, MA.

Company Profile

SymbolMBIO
Company NameMustang Bio
Listing DateAug 22, 2017
CEODr. Manuel Litchman, M.D.
MarketNASDAQ
Employees80
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address377 Plantation Street,1st floor
CityWorcester
ProvinceMassachusetts
CountryUnited States of America
Zip Code01605-2245
Phone1-781-652-4500

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Manuel Litchman, M.D.
  • Director, President and Chief Executive Officer
  • 656.67K
  • James Murphy
  • Interim Chief Financial Officer and Principal Accounting Officer
  • --
  • Michael S. Weiss
  • Executive Chairman of the Board
  • 110.00K
  • Dr. Lindsay A. Rosenwald, M.D.
  • Director
  • 100.00K
  • Neil Herskowitz
  • Independent Director
  • 100.00K
  • Adam J. Chill
  • Independent Director
  • 110.00K
  • Dr. Michael J. Zelefsky, M.D.
  • Independent Director
  • 100.00K
  • Peter Carney
  • Controller
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg